Middle East Respiratory Syndrome: MERS

Middle East Respiratory Syndrome: MERS

Emine Parlak

Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly emerging respiratory virus. It was first identifiedin Saudi Arabia in 2012. MERS-CoV infection is characterized by a spectrum of illness ranging from mild to acute andfulminant disease. The majority of patients present with fever, fever with chills/rigors, cough, shortness of breath, anddry cough. Cases of human-to-human transmission have been documented. There is currently no specific treatmentand vaccination for MERS-CoV infection. Surveillance and infection-control measures are of vital importance to an efficientpublic health response. J Microbiol Infect Dis 2015;5(2): 93-98

2015

coronavirus, Middle East respiratory syndrome, MERS-CoV polymerase-chain-reaction

DOI: 10.5799/ahinjs.02.2015.02.0184

Journal of Microbiology and Infectious Diseases

Association of Health Investigations

Microbiology

EN